BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26060645)

  • 1. The Effectiveness of Harm Reduction Programs in Seven Prisons of Iran.
    Roshanfekr P; Farnia M; Dejman M
    Iran J Public Health; 2013 Dec; 42(12):1430-7. PubMed ID: 26060645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
    Chakrapani V; Kamei R; Kipgen H; Kh JK
    Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of drugs in Australian prisons: supply reduction strategies.
    Dolan K; Rodas A
    Int J Prison Health; 2014; 10(2):111-7. PubMed ID: 25764074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost implications of random mandatory drugs tests in prisons.
    Gore SM; Bird AG
    Lancet; 1996 Oct; 348(9035):1124-7. PubMed ID: 8888165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison.
    Small W; Kain S; Laliberte N; Schechter MT; O'Shaughnessy MV; Spittal PM
    Subst Use Misuse; 2005; 40(6):831-43. PubMed ID: 15974143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug and alcohol use and treatment for Australian Indigenous and non-Indigenous prisoners: demand reduction strategies.
    Dolan K; Rodas A; Bode A
    Int J Prison Health; 2015; 11(1):30-8. PubMed ID: 25751705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trend of HIV/AIDS Prevalence and Related Interventions Administered in Prisons of Iran -13 Years' Experience.
    Shahbazi M; Farnia M; Rahmani K; Moradi G
    Iran J Public Health; 2014 Apr; 43(4):471-9. PubMed ID: 26005657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social characteristics, HIV/AIDS knowledge, preventive practices and risk factors elicitation among prisoners in Lagos, Nigeria.
    Odujinrin MT; Adebajo SB
    West Afr J Med; 2001; 20(3):191-8. PubMed ID: 11922150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran.
    Moradi G; Farnia M; Shokoohi M; Shahbazi M; Moazen B; Rahmani K
    Int J Health Policy Manag; 2015 Mar; 4(9):583-9. PubMed ID: 26340487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?
    Ekhtiari H; Noroozi A; Farhoudian A; Radfar SR; Hajebi A; Sefatian S; Zare-Bidoky M; Razaghi EM; Mokri A; Rahimi-Movaghar A; Rawson R
    Addiction; 2020 Jul; 115(7):1395-1403. PubMed ID: 31737965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indonesian prisons and HIV: part of the problem, part of the solution?
    Nelwan EJ; Diana A; van Crevel R; Alam NN; Alisjahbana B; Pohan HT; van der Ven A; Djaya I
    Acta Med Indones; 2009 Jul; 41 Suppl 1():52-6. PubMed ID: 19920299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injecting drug use, sexual risk, HIV knowledge and harm reduction uptake in a large prison in Bali, Indonesia.
    Sawitri AA; Hartawan AA; Craine N; Sari AK; Septarini NW; Wirawan DN
    Int J Prison Health; 2016; 12(1):27-38. PubMed ID: 26933990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/AIDS behind bars.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1998 Apr; 4(4):8-13. PubMed ID: 11365184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS in Mexican prisons.
    Olivero JM; Roberts JB
    AIDS Soc; 1995; 6(4):4. PubMed ID: 12290151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico.
    Heimer R; Catania H; Newman RG; Zambrano J; Brunet A; Ortiz AM
    Drug Alcohol Depend; 2006 Jun; 83(2):122-9. PubMed ID: 16332415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Random mandatory drugs testing of prisoners: a biassed means of gathering information.
    Gore SM; Bird AG; Strang JS
    J Epidemiol Biostat; 1999; 4(1):3-9. PubMed ID: 10613711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of drug abuse in prisoners in a major correctional institution.
    Sobota JT; Lummis L
    Clin Toxicol; 1974; 7(5):531-9. PubMed ID: 4442249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polydrug use and self control among men and women in prisons.
    Kassebaum G; Chandler SM
    J Drug Educ; 1994; 24(4):333-50. PubMed ID: 7869224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV transmission among male inmates in a state prison system--Georgia, 1992-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Apr; 55(15):421-6. PubMed ID: 16628181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.